GSK PLC-SPON ADR (GSK)       36.6  -0.28 (-0.76%)

36.6  -0.28 (-0.76%)

US37733W2044 - ADR - After market: 36.59 -0.01 (-0.03%)

EPS Estimates (GBP)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 0.94 0.82 0.1214.45% Q2 2022 0.70 0.60 0.1016.49% Q1 2022 0.82 0.78 0.044.62% Q4 2021 0.64 0.63 0.011.36% Q3 2021 0.92 0.75 0.1722.51% Q2 2021 0.71 0.52 0.1935.82% Q1 2021 0.58 0.55 0.023.70% Q4 2020 0.59 0.60 -0.02-2.81%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 2.66 2.84 -6.65%Q4 2022 0.50 0.64 -22.84%FY 2023 2.90 2.66 9.37%Q1 2023 0.72 0.82 -12.02%Q2 2023 0.69 0.70 -0.27%Q3 2023 0.87 0.94 -7.98%Q4 2023 0.62 0.50 24.73%FY 2024 3.15 2.90 8.41%FY 2025 3.33 3.15 5.72%FY 2026 3.62 3.33 8.89%

Revenue Estimates (GBP)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 7.829B 7.555B 274M3.63% Q2 2022 6.929B 6.702B 227M3.39% Q1 2022 7.19B 9.265B -2.075B-22.40% Q4 2021 9.527B 9.782B -255M-2.61% Q3 2021 6.627B 8.986B -2.359B-26.25% Q2 2021 5.838B 7.785B -1.947B-25.01% Q1 2021 7.418B 8.12B -702M-8.65% Q4 2020 8.739B 9.001B -262M-2.91%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 29.384B 34.114B -13.87%Q4 2022 7.678B 9.527B -19.41%FY 2023 30.175B 29.384B 2.69%Q1 2023 6.582B 7.19B -8.46%Q2 2023 7.114B 6.929B 2.67%Q3 2023 7.92B 7.829B 1.16%Q4 2023 8.177B 7.678B 6.50%FY 2024 32.24B 30.175B 6.84%FY 2025 32.047B 32.24B -0.60%FY 2026 32.2B 32.047B 0.48%